Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A phase 1, multicenter, open-label, dose escalation study... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
0
Authors
Jeffrey Zonder
8 more
Jeffrey Zonder
•
Ann Mohrbacher
6 more
•
Anil Singhal
Published
December 20, 2011
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Gastroenterology
Show all topics
DOI
10.1182/blood-2011-06-360552
